Figure 2 | Scientific Reports

Figure 2

From: Serum lipid profile in HCV patients treated with direct-acting antivirals: a systematic review and meta-analysis

Figure 2

Serum total cholesterol changes after treatment completion. Forest plot for mean difference (MD) and 95% confidence intervals (CI) for each time-point. DCV/ASV daclatasvir/asunaprevir, SOF/LDV sofosbuvir/ledipasvir, SOF/RBV sofosbuvir + ribavirin, SOF/SMV sofosbuvir/simeprevir, GRZ/EBV grazoprevir/elbasvir, PrOD paritaprevir/ritonavir/ombitasvir + dasabuvir, SVR12 Sustained virological response at 12 weeks; SVR24: Sustained virological response at 24 weeks.

Back to article page